Vanda Pharmaceuticals News and Activities

Presence

Vanda Pharmaceuticals develops and sells prescription medicines for rare diseases and central nervous system conditions. Its products and support services serve patients, physicians, and healthcare providers.

Vanda Pharmaceuticals products and services overview:

Prescription medicines
Rare disease therapies
Neurology treatments
Sleep disorder treatments
Patient support services

Revenue: ~$190 million

Employees: 380

Headquarters: Washington, United States (USA)

Vanda Pharmaceuticals is one of the...

Vanda Pharmaceuticals is a company listed under the stock ticker VNDA (US).

Acquisition, funding and merger involving Vanda Pharmaceuticals.

Vanda Pharmaceuticals and Cycle Pharmaceuticals have announced they will merge (posted on October 16 2024)..

Executives

View the org chart displaying its 13 main executives

Most searched biographies at Vanda Pharmaceuticals

Popular executive movements at Vanda Pharmaceuticals

Charles Duncan has joined the company as Director (posted on April 24 2026).
Timothy Williams, Senior Vice President, General Counsel and Secretary, has left the company (posted on April 13 2026).

Create your alert
to follow the executive moves at Vanda Pharmaceuticals.